Contact This Organization

C19.ai

In an effort to accelerate COVID-19 biomedical discoveries, Omic developed C19.ai. C19 enables collaboration in a virtual lab between computational biologists, data scientists, and health professionals in order to reverse engineer SARS-CoV-2. Omic launched the platform on June 26th and within the first week approximately 100 researchers had joined and formed 9 collaborative projects across multiple computational biology, virology, and AI research areas.
Mission/Vision
C19.ai connects each of us with the medical and genetic research community to help bring an end to the COVID-19 pandemic.
Type of Organization
Startup - Newly established businesses, investable
Researcher/Academic
Size of Organization
0-10
Organization Mailing Address

745A Harvard Ave E
Seattle, WA 98102
United States

COVID-19 AI Analysis Portal
C19 acts as an operating system, with the ability to ingest data into a digital cloud biobank, run SARS-CoV-2 bioinformatics pipelines, design and execute artificial intelligence models with Jupyter notebooks, and run AI-enabled clinical analytics. A high-level technical architecture is shown below.
Category of Innovation
Digital Health - A digital health solution is a technology-based solution whose user is caring for or providing care for themselves (think of a personal app) or another individual (such as a doctor using a tool to help their patient)
Intended End User
Provider - Individuals or organizations responsible for providing care to patients (e.g. doctors, nurses, hospital/clinic administrators, etc.)
Startup - newly established business, investable
Researcher/Academic
Impactful Innovation Stage (Click Here for Details)
Adoption
Problem (i.e. barrier, issue, complication, etc.) being solved for the end user
Since the World Health Organization declared COVID-19 a pandemic in March, academics, governments, and companies have generated numerous and valuable SARS-CoV-2 data and evidence. While altruistic organizations have made substantial progress in organizing open data assets (CORD-19, Shelter in Place Index) and researchers (COVID-19 NSVD, Crowdfight COVID-19), fewer advances have materialized in open, centralized scientific research.
Funding Stage
Seed